If you find a reputable link or resource that you feel would be a useful addition to this site, please submit your suggestion HERE



Metastatic Melanomas Respond to Immunotherapy Combo in Early Clinical Study
By Ozge Ozkaya, PHD - July 28, 2016

The immune-therapy drug ipilimumab, together with talimogene laherparepvec or T-VEC, showed positive results in a Phase 1b clinical trial of metastatic melanoma patients who did not respond to other treatments and whose tumors could not be surgically removed.

The study, “Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma,” was published in the Journal of Clinical Oncology...
Read full article...



Skin cancer: Pair of drugs 'eliminate 20% of tumours'
By James Gallagher Health editor, BBC News website

A fifth of people with advanced melanoma have no sign of tumours in their body after treatment with a pair of immunotherapy drugs, a study shows.
The first survival data on using ipilimumab and nivolumab in combination showed 69% of patients, in a trial on 142, were still alive after two years.
Read full article...
















About Meredith's Mission  |  How You Can Help  |  Melanoma Awareness  |  Resources  |  Contact  |  Home

Copyright © 2016 Meredith's Mission For Melanoma | All Rights Reserved.